Evidence map›Paper›PMID 30148232›Full record

ReviewTranslational gastroenterology and hepatology2018

Branched-chain amino acids in liver diseases.

Kazuto Tajiri, Yukihiro Shimizu

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Translational gastroenterology and hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06121479 phase3enrolling by invitationnot on this mapstarted 2023, after this paper: background citation

Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients: a Pilot Study

TypeinterventionalSponsorMahidol UniversityRan2023 to 2025Enrolled30ConditionsDecompensated Cirrhosis and AscitesArmsBranched-chain amino acid
NCT06121492 phase3enrolling by invitationnot on this mapstarted 2023, after this paper: background citation

Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia: a Double-blinded Randomized Controlled Trial

TypeinterventionalSponsorMahidol UniversityRan2023 to 2026Enrolled86ConditionsSarcopenia, Cirrhosis of the LiverArmsBranched-chain amino acid, Placebo
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kazuto TajiriDepartment of Gastroenterology, Toyama University Hospital, Toyama, Japan.
Yukihiro ShimizuGastroenterology Unit, Nanto Municipal Hospital, Nanto, Japan.
Toyama University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Branched chain amino acids (BCAAs) are involved in various bioprocess such as protein metabolism, gene expression, insulin resistance and proliferation of hepatocytes. BCAAs have also been reported to suppress the growth of hepatocellular carcinoma (HCC) cells

Indexed as

Branched chain amino acids (BCAAs)cirrhosishepatocarcinogenesisimmunitymammalian target of rapamycin signal (mTOR signal)

Identifiers

PMID30148232
PMCPMC6088198
OpenAlexW2885967217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.